跳至主要内容
临床试验/TCTR20200430004
TCTR20200430004Unknown4 期

Comparative study of efficacy and safety of Yahom-Navakot remedy plus Levofloxacin vs Levofloxacin alone in prevention of nosocomial infection in post-cardiac arrest patients treated by targeted temperature management: A randomized, double blinded, p

Thammasat University0 个研究点目标入组 60 人开始时间: 2020年4月30日最近更新:
适应症

试验速览

阶段
4 期
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 90 Years(—)
性别
All

入选标准

  • 1.Ventricular fibrillation or pulseless ventricular tachycardia
  • 2. Witnessed arrest
  • 3. Glassgow Coma scale(GCS) < 8
  • 4. Systolic Blood Pressure > 90 mmHg
  • 5. Receive Targeted Temperature Management
  • 6. Male and female with age 20-90 year old

排除标准

  • 1. Known allergy to Yahom-Navakot remedy or levofloxacin
  • 2. Terminal illness
  • 3. Pregnancy and lactation
  • 4. Known infection with antibiotic usage within 1 week
  • 5. abnormal clotting with unable to recovery
  • 6. GI bleeding
  • 7. unable to have NG-tube feeding or GI malabsorption

研究者

相似试验